Crossmark

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania

Published Online: 2018-10-17

Published Print: 2018-12

Authors

Kakolwa, Mwaka A.

Mahende, Muhidin K.

Ishengoma, Deus S.

Mandara, Celine I.

Ngasala, Billy

Kamugisha, Erasmus

Kataraihya, Johannes B.

Mandike, Renata

Mkude, Sigsbert

Chacky, Frank

Njau, Ritha

Premji, Zul

Lemnge, Martha M.

Warsame, Marian

Menard, Didier

Kabanywanyi, Abdunoor M.
Clinical Trials ^BETA

Clinical trials referenced in this document:

actrn12615000159550 at Australian New Zealand Clinical Trials Registry

Documents that mention this clinical trial

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
https://doi.org/10.1186/s12936-018-2524-x
Funding

Funding for this research was provided by:

The US President Malaria Initiatives,USAID

World Health Organization
License Information

Text and Data Mining valid from 2018-10-17

Version of Record valid from 2018-10-17
More Information

Article History

Received: 20 April 2018

Accepted: 9 October 2018

First Online: 17 October 2018

Document is current